Bley, Oliver,Loos, Petra,Bidlingmaier, Bernd,Kamm, Walter,Berchtold, Harald
申请号：
AU2015205620
公开号：
AU2015205620A1
申请日:
2015.01.08
申请国别(地区):
AU
年份:
2016
代理人:
摘要：
Stabilized pharmaceutical formulations of insulin aspart are disclosed. In particular the application is directed to a pharmaceutical formulation comprising (a) insulin aspart； and (b) Zn(ll)； and (e) optionally protamine； wherein the pharmaceutical formulation contains less than 0.17 mg/mL sodium chloride.
